ID,Seed,Run time,Rate of gonorrhea cases (average incidence after epidemic warm-up),Time-averaged proportion of cases CIP-S (average incidence after epidemic warm-up),Time-averaged proportion of cases TET-S (average incidence after epidemic warm-up),Time-averaged proportion of cases CRO-S (average incidence after epidemic warm-up),Time-averaged proportion of cases CIP/TET-NS (average incidence after epidemic warm-up),"Time-averaged proportion of cases treated successfully with CIP, TET, or CRO (average incidence after epidemic warm-up)",Time-averaged proportion of cases treated successfully with CIP (average incidence after epidemic warm-up),Time-averaged proportion of cases treated successfully with TET (average incidence after epidemic warm-up),Time-averaged proportion of cases treated successfully with CRO (average incidence after epidemic warm-up),Duration of 1st line therapy with CRO (after epidemic warm-up),Duration of 1st line therapy with Drug M (after epidemic warm-up)
0,1763909319,3.027623414993286,0.0940089948214381,0.6850346693274426,0.1723905307633443,0.9585484285141906,0.8028652928517994,0.43651362125105264,0.0,0.0,0.43651362125105264,10.0,14.0
1,1489933983,2.914044141769409,0.0811837454940641,0.7510333365707764,0.153350605200994,0.9679630017019103,0.8302756991151625,0.5167481219157399,0.0,0.0,0.5167481219157399,12.0,12.0
2,453741709,2.609945058822632,0.09524501767878078,0.7434943846416161,0.19034008735828897,0.9562868619901126,0.7899593345904629,0.43608619452870895,0.0,0.0,0.43608619452870895,10.0,14.0
3,811108630,2.577725648880005,0.08024807198706331,0.72541033514359,0.14606994189900585,0.9597216439226033,0.8307960741979606,0.6352752150821105,0.0,0.0,0.6352752150821105,15.0,9.0
